Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients.

Tolaney, Sara M; Ziehr, David R; Guo, Hao; Ng, Mei R; Barry, William T; Higgins, Michaela J; Isakoff, Steven J; Brock, Jane E; Ivanova, Elena V; Paweletz, Cloud P; Demeo, Michelle K; Ramaiya, Nikhil H; Overmoyer, Beth A; Jain, Rakesh K; Winer, Eric P; Duda, Dan G

Tolaney, Sara M; Ziehr, David R; Guo, Hao; Ng, Mei R; Barry, William T; Higgins, Michaela J; Isakoff, Steven J; Brock, Jane E; Ivanova, Elena V; Paweletz, Cloud P; Demeo, Michelle K; Ramaiya, Nikhil H; Overmoyer, Beth A; Jain, Rakesh K; Winer, Eric P; Duda, Dan G.

Oncologist ; 26(8): e1483, 2021 Aug.

Article en En | MEDLINE | ID: mdl-33978307

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342577
https://dx.doi.org/10.1002/onco.13809

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342577
https://dx.doi.org/10.1002/onco.13809

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article